The cellular prion protein beyond prion diseases.
Journal
Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884
Informations de publication
Date de publication:
20 04 2020
20 04 2020
Historique:
entrez:
25
4
2020
pubmed:
25
4
2020
medline:
19
8
2021
Statut:
epublish
Résumé
The cellular prion protein (PrPC), a cell surface glycoprotein originally identified for its central role in prion diseases (also called transmissible spongiform encephalopathies), has recently been implicated in the pathogenesis of other neurodegenerative disorders, such as Alzheimer’s and Parkinson’s diseases, by acting as a toxicity-transducing receptor for different misfolded protein isoforms, or in some case by exerting neuroprotective effects. Interestingly, PrPC has also been reported to play unexpected functions outside the nervous system, for example by contributing to myelin homeostasis, regulating specific processes of the immune system and participating in various aspects of cancer progression. Collectively, these observations point to a much broader role for PrPC in physiological and disease processes than originally assumed. In this manuscript, we provide an overview of what is known about the role of PrPC beyond prion disorders and discuss the potential implications of targeting this protein in different diseases.
Identifiants
pubmed: 32330284
doi: 10.4414/smw.2020.20222
pii: Swiss Med Wkly. 2020;150:w20222
doi:
pii:
Substances chimiques
Prion Proteins
0
Prions
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM